Skip to content
Luna Metabolic
Menu
Ranked #49 for women · Grade C

HealthSource review

One of the few programs that documents its all-50-state footprint rather than asserting it, with an oral tirzepatide route and a starter-dose plan priced the same as the full dose.

Visit HealthSource Assume any provider we list may compensate us — we may earn a commission, at no cost to you. See our disclosure.
Semaglutide
$199 every 4 weeks (13 charges a year; $174.50 per 4 weeks on the 8-week plan)
Tirzepatide
$299 every 4 weeks (13 charges a year; $274.50 per 4 weeks on the 8-week plan)
Coverage
All 50 states
Brand-name
Compounded only

The Luna Fit scorecard

HealthSource scored on our six women's-health factors. See the methodology.

PCOS & hormonal suitability60/100
Clinical oversight & labs72/100
Price transparency70/100
Nationwide access95/100
Ongoing support82/100
Cancellation fairness70/100

What we like

  • The only provider in this batch whose all-50-state claim is documented on its own service-areas page rather than asserted in marketing copy
  • An oral tirzepatide programme alongside the injections
  • Starter-dose and full-dose plans cost the same, so titrating up does not raise the bill
  • An 8-week plan brings semaglutide to $174.50 per four weeks, which the price ladder does not advertise
  • Medication, supplies and 24/7 care-team messaging are all inside the plan price with no membership fee
  • Clinical care runs through MD Integrations, named rather than described vaguely
  • Automatic refund if a monthly reassessment is not filled

The caveats

  • Billed every four weeks, not monthly — thirteen charges a year, so the effective annual cost is about 8% above the sticker
  • Never actually claims flat pricing across all doses; the variants it sells happen to cost the same
  • The form of the oral tirzepatide — sublingual, troche or swallowed tablet — is not disclosed anywhere
  • No lab or monitoring programme at all; oversight is a monthly reassessment and messaging
  • The compounding pharmacy is not named, and individual practitioners are not listed
  • Charges already processed are non-refundable, and dispensed prescriptions cannot be refunded
  • No menopause, PCOS, hormone or contraception content on any GLP-1 page

The bottom line

Best for: Women who want an oral tirzepatide option and a documented nationwide footprint, and who will read the four-week billing cycle rather than assuming it is monthly. One of the few programs that documents its all-50-state footprint rather than asserting it, with an oral tirzepatide route and a starter-dose plan priced the same as the full dose.

Ranked #49 of 54 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. PCOS & hormonal suitability is where HealthSource scores lowest, at 60/100. If that is your sticking point, start with the full field we rank against HealthSource.

Compare with other providers

All 53 other providers we've reviewed for women, in our overall ranking order. One of those comparisons is written out in full: how HealthSource and CoreAge Rx compare on the Luna Fit Score, 19 points apart on the Luna Fit Score. Directly below HealthSource sits Cielo at #50 with 73/100 — see the alternatives to Cielo we rank for women if that is the band you are shopping in.

Pricing, states and verification reflect HealthSource's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on HealthSource's site. Not medical advice; see our disclosure.

← Back to all providers